Skip to content
Screener

Lexicon Pharmaceuticals LXRX Q2 2026 earnings

Reported August 6, 2026 · Before market open

Revenue$692.0KMiss by $3.3M
EPS-$0.06Miss by $0.01
Revenue estimate$4.0M
EPS estimate-$0.05
“Among all the accomplishments, I'm particularly pleased that we have completed enrollment of our SONATA-HCM study on time, reflecting strong clinical interest for a novel class of medicine to treat HCM. Overall, I could not be more confident in how these opportunities are poised to shape the company over the coming months.”
Mike Exton

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$2.8M
EPS estimate-$0.06

Financials

Q2 2026

Income statement

See full
Revenue$692.0K-97.6%
Gross profit$653.0K-97.7%
Operating income-$26.5M-810%
Net income-$31.8M-1,077%
EPS (diluted)-$0.07-800%

Balance sheet

See full
Cash & equivalents$40.9M-18.7%
Total debt$59.2M-3.6%
Total equity$174.5M+34.8%
Total assets$250.1M+10.9%

Cash flow

See full
Operating cash flow-$9.2M—

Valuation & ratios

Valuation

as of 09/17/26
See full
Market cap$898.81M+127%
Enterprise value$917.13M+125%
P/S21.7×+14.9×

Profitability

See full
Gross margin99.1%0.0pp
Operating margin-131.4%-34.2pp
Net margin-147.4%-32.8pp

Returns & leverage

See full
Return on equity-40.2%-11.2pp
Debt / equity0.3×-0.1×
Current ratio13.4×+9.2×

Segments

By segment

See full
Reportable Segment$692.0K-97.6%

By product

See full
License--100%

FAQ

When did Lexicon Pharmaceuticals report Q2 2026 earnings?
Lexicon Pharmaceuticals (LXRX) reported Q2 2026 earnings on August 6, 2026 before market open.
What were Lexicon Pharmaceuticals's Q2 2026 revenue and EPS?
Lexicon Pharmaceuticals reported revenue of $692.0K and eps of $-0.06 for Q2 2026.
Did Lexicon Pharmaceuticals beat estimates in Q2 2026?
Revenue missed the consensus estimate of $4.0M by $3.3M. EPS missed the consensus estimate of $-0.05 by $0.01.
How did Lexicon Pharmaceuticals's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 97.6% from $28.9M a year earlier.
Where can I find Lexicon Pharmaceuticals's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001062822-26-000112) and the 10-Q periodic report (0001062822-26-000117) directly on SEC EDGAR. The filing index links above go to sec.gov.